Roy Gerona

134 papers receiving 4.5k citations

Roy Gerona's Hit Papers

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial 2017 · 410 citations
4100+3+6Years since publication100200300400

Peers

Roy Gerona
Comparison fields: 5 of 146
  • Toxicology 1.4k
  • Pharmacology 953
  • Health, Toxicology and Mutagenesis 663
  • Developmental Neuroscience 181
  • Cellular and Molecular Neuroscience 672
Replace Bindu D. Paul with:
Bindu D. Paul United States
Diana G. Wilkins United States
Helena Carmo Portugal
Arthur K. Cho United States
Jan van Amsterdam Netherlands
A. Schmoldt Germany
Emilio Russo Italy
Norbert E. Kaminski United States
Corinne Charlier Belgium
Alphonse Poklis United States
Roy Gerona relative to Bindu D. Paul United States Bindu D. Paul's profile →
Citations per field
00.5×5.5×
Bindu D. Paul · 1×
Citations per year

Countries citing papers authored by Roy Gerona

Since Specialization
Citations

This map shows the geographic impact of Roy Gerona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Gerona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Gerona more than expected).

Fields of papers citing papers by Roy Gerona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Gerona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Gerona. The network helps show where Roy Gerona may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy Gerona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Gerona Line = papers co-authored together Roy Gerona links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Hit paper breakdown →
2017410
2
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Hit paper breakdown →
2016230
3 2015230
4 2000193
5 2013157
6 2018145
7 2004143
8 2012142
9 2016121
10 2019102
11 200899
12 201492
13 201487
14 201684
15 202080
16 201278
17 201576
18 202071
19 201670
20 200569

About Roy Gerona

Roy Gerona is a scholar working on Toxicology, Pharmacology, Health, Toxicology and Mutagenesis, Emergency Medicine and Molecular Biology, having authored 136 papers that have together received 4.6k indexed citations. Recurring topics across this work include Forensic Toxicology and Drug Analysis (59 papers), Cannabis and Cannabinoid Research (26 papers), Effects and risks of endocrine disrupting chemicals (17 papers), Poisoning and overdose treatments (12 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Psychedelics and Drug Studies (8 papers), Toxic Organic Pollutants Impact (8 papers) and Alcohol Consumption and Health Effects (7 papers). The work is most often cited by research in Toxicology (1.4k citations), Pharmacology (953 citations), Health, Toxicology and Mutagenesis (663 citations), Developmental Neuroscience (181 citations) and Cellular and Molecular Neuroscience (672 citations). Roy Gerona has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Jordan Trecki, Michael D. Schwartz, Thomas F.J. Martin, Samuel D. Banister, Judith A. Kowalchyk, Patil Armenian, Alan H.B. Wu, Eric Larsen, Axel Adams and Kara L. Lynch. Their work appears in journals such as Clinical Toxicology, Drug Testing and Analysis, ACS Chemical Neuroscience, Journal of Emergency Medicine and Journal of Medical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact